The Rheumatology Podcast

Professor Robert Moots and Dr Alfred Mahr discuss the challenges of ANCA-associated vasculitis, use of cyclophosphamide and granulomotosis with angiitis. They also discuss the use of rituximab particularly in light of the recommendations published by

How do you manage refractory rheumatoid arthritis? Listen to Professor Robert Moots, Editor, and Professor Paul Peter Tak from the University of Amsterdam, discuss advances in the treatment of RA and consider differences between clinical trials and r

How do you manage refractory rheumatoid arthritis? Listen to Professor Robert Moots, Editor, and Professor Paul Peter Tak from the University of Amsterdam, discuss advances in the treatment of RA and consider differences between clinical trials and r

Professor Robert Moots talks to Dr Fernando Cavalcanti about inflammatory arthritis and its treatment in Brazil, highlighting cultural differences in disease management and between patient and Doctor perceptions. They also discuss a review by Versch

Professor Robert Moots and Professor Janet Pope talk about treatment strategies for early rheumatoid arthritis and the influence cost-effectiveness has. To further highlight the issues they discuss a paper by Schipper et al. comparing the cost-effec

Professor Robert Moots and Dr Piet van Riel discuss the treatment of inflammatory myopathies and their efficacies in patients. They talk about a paper, on which Dr van Riel is a co-author, investigating the use of rituximab to treat refractory infla

Professor Robert Moots and Professor Janet Pope talk about treatment strategies for early rheumatoid arthritis and the influence cost-effectiveness has. To further highlight the issues they discuss a paper by Schipper et al. comparing the cost-effec

Professor Robert Moots and Professor Janet Pope talk about treatment strategies for early rheumatoid arthritis and the influence cost-effectiveness has. To further highlight the issues they discuss a paper by Schipper et al. comparing the cost-effec

Professor Robert Moots and Dr Piet van Riel discuss the treatment of inflammatory myopathies and their efficacies in patients. They talk about a paper, on which Dr van Riel is a co-author, investigating the use of rituximab to treat refractory infla

Professor Robert Moots talks to Dr Fernando Cavalcanti about inflammatory arthritis and its treatment in Brazil, highlighting cultural differences in disease management and between patient and Doctor perceptions. They also discuss a review by Versch